Skip to main content
Top
Published in: Malaria Journal 2/2010

Open Access 01-12-2010 | Poster presentation

kdr-like mutations in the voltage gated sodium channel of a malaria vector Anopheles stephensi and development of PCR-based assays for their detection

Authors: OP Singh, CL Dykes, T Adak

Published in: Malaria Journal | Special Issue 2/2010

Login to get access

Excerpt

Knockdown resistance (kdr) in insects resulting from mutation(s) in the voltage gated sodium channel (VGSC) gene is one of the mechanisms of resistance against DDT and pyrethroid group of insecticides. The most common mutation(s) associated with knock down resistance has been reported to be present at residue Leu1014 in the IIS6 transmembrane segment of the VGSC gene. The present study reports presence of two alternative kdr-like mutations in An. stephensi— L1014S and L1014S, and development of PCR-based assays for their detection. …
Metadata
Title
kdr-like mutations in the voltage gated sodium channel of a malaria vector Anopheles stephensi and development of PCR-based assays for their detection
Authors
OP Singh
CL Dykes
T Adak
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 2/2010
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-9-S2-P67

Other articles of this Special Issue 2/2010

Malaria Journal 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.